Current Status and Future Direction of Transcatheter Mitral Valve Replacement

Z. Meng,E. Zhang,Yong-Jian Wu

DOI: https://doi.org/10.4103/0366-6999.226080

IF: 6.133

2018-03-05

Chinese Medical Journal

Abstract:Valvular heart disease (VHD) refers to the disorder of cardiac valves leading to valvular regurgitation or stenosis. Severe VHD will result in chronic heart failure and cardiac death. The only large population‐based epidemiologic study involving echocardiography was performed in the United States in 2006. In this study, the prevalence of VHD in the United States was estimated to be 2.5%.[1] As a developing country, VHD caused by rheumatic heart disease is still a huge burden in China. It is estimated that there were around 7.07 million patients with rheumatic heart disease in China in 2015.[2] In addition, as life expectancy increases, the prevalence of the degenerative valvular disease increases sharply according to a regional survey in Xinjiang, which reported that the prevalence of degenerative valvular disease in Han elderly (mean age 67.7 years old) was 30.2%. Hence, due to Chinese socioeconomic characters, both rheumatic heart disease and degenerative valve disease contribute to the high burden of VHD in China. However, there is no national cross‐sectional study to uncover the epidemiologic features of VHD in China. Our group is currently conducting the first degenerative valve disease cross‐sectional study in China, aiming to provide a demographic profile of degenerative mitral valve disease nationwide. On this basis, a national multicenter registry will be started to build an adult severe VHD database in China.